register

Medical and Science

National consultation to set MRFF medical research priorities

Health Industry Hub | September 16, 2020 |

Medical News: A national consultation process will guide the third set of the Morrison Government’s ground-breaking Medical Research Future Fund (MRFF) Australian Medical Research and Innovation Priorities for 2020–2022.

This consultation process will ensure the MRFF continues to target national health priorities for better health outcomes.

Nadia Levin, CEO and Managing Director said “With the MRFF reaching full capitalisation of $20 billion this year, it plays as key funding role for all stages of Australian health and medical research. As we have throughout the history of MRFF, Research Australia will be engaging closely in the development of the next set of priorities to ensure that all stages of the medical research pipeline can benefit. It will be central to growing our sector and positioning Australia as a global leader in health and medical research and innovation.”

Determining future health priorities is about taking into account the burden of disease in Australians and the need to enhance the translation of research into clinical practice.

Australia’s health and medical researchers are world class and the Government continues to drive investment in ways that deliver the practical benefits of medical research and innovation to all Australians.

The landmark $20 billion MRFF is enhancing this growth in Australia’s cutting-edge health and medical research.

Join 22,000+
industry professionals
in accessing the latest 
industry news, scientific insights & engaging professional development 
content from
Health Industry HubTM, 
the ONLY one-stop-hub
connecting Australia’s 
Pharma, MedTech & Biotech
industry professionals. Register now.

It is leading to new cures and treatments across Australia—saving lives and improving lives. The Australian public, organisations with expertise in health and medical research and innovation, consumer representatives, clinicians and health services managers are invited to contribute to the consultation.

Consultation is now open to inform the development of the Medical Research Future Fund (MRFF) Australian Medical Research and Innovation Priorities for 2020–22.

The Australian Medical Research Advisory Board is seeking comment from interested parties through online submissions and public webinars until 7 October 2020.

Visit the Department of Health’s Consultation Hub to see how you can comment online.


Medical and Science

NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders

NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders

Health Industry Hub | September 6, 2024 |

Medical & Science: NACCHO has announced the recipients of the 2024 Aboriginal and Torres Strait Islander Pharmacy Leadership Grant: Jes […]

More


ESG

First report exposes glaring gaps in healthcare sector sustainability

First report exposes glaring gaps in healthcare sector sustainability

Health Industry Hub | September 6, 2024 |

ESG: The first comprehensive report outlining sustainability and decarbonisation efforts in the Australian healthcare sector has been released, aimed at […]

More


News & Trends - Pharmaceuticals

Expanded access to Shingrix is a start: 'We need reform for all current and future vaccines'

Expanded access to Shingrix is a start: ‘We need reform for all current and future vaccines’

Health Industry Hub | September 6, 2024 |

Pharma News: Access to GSK’s Shingrix vaccine, following the 2023-24 federal budget decision, has been limited to “immunocompromised patients aged […]

More


News & Trends - Pharmaceuticals

NSW government fails to back mental health inquiry findings with essential funding

NSW government fails to back mental health inquiry findings with essential funding

Health Industry Hub | September 6, 2024 |

NSW Government has support for 24 of 39 recommendations from the Portfolio Committee’s Inquiry Report on ‘Equity, accessibility and appropriate […]

More


This content is copyright protected. Please subscribe to gain access.